Moreover, we previously demonstrated a significant reduction of both - NR4A1 and NR4A3 – in major B cell neoplasms like chronic lymphocytic leukaemia (CLL), FL and DLBCL compared to normal controls9. This evidence concerns the gene NR4A3 and B-cell chronic lymphocytic leukemia.